The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities
- PMID: 19164271
- PMCID: PMC2691192
- DOI: 10.1093/gerona/gln020
The emerging threat of multidrug-resistant gram-negative organisms in long-term care facilities
Abstract
Background: Infections caused by antimicrobial-resistant bacteria are associated with substantial morbidity and mortality. Residents of long-term care facilities (LTCF) are among the main reservoirs of antimicrobial-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Multidrug-resistant gram-negative organisms (MDRGN) are emerging as important pathogens among LTCF residents. Data on the clinical epidemiology of MDRGN, especially in comparison to VRE and MRSA, are limited.
Methods: All clinical cultures collected from residents of a 750-bed LTCF for a period of 2 years were analyzed for the presence of MDRGN, VRE, and MRSA. Multidrug resistance among gram-negative bacteria was defined as resistance to three or more antimicrobials or antimicrobial groups including extended-spectrum penicillins (ampicillin/sulbactam or piperacillin/tazobactam), cephalosporins (cefazolin or ceftriaxone), gentamicin, ciprofloxacin, and trimethoprim-sulfamethoxazole (TMP/SMX).
Results: A total of 1,661 clinical cultures were included in the analysis. MDRGN were recovered from 180 (10.8%) cultures, MRSA from 104 (6.3%), and VRE from 11 (0.6%). MDRGN were isolated more frequently than MRSA or VRE throughout the study period. The prevalence of MDRGN increased significantly from 7% in 2003 to 13% in 2005 (p = .001). More than 80% of MDRGN isolates were resistant to ciprofloxacin, TMP/SMX, and ampicillin/sulbactam. Resistance to three, four, and five or more antimicrobials were identified among 122 (67.8%), 47 (26.1%), and 11 (6.1%) MDRGN isolates, respectively.
Conclusions: Rates of MDRGN exceeded those of MRSA and VRE and increased throughout the study period. Resistance to multiple, commonly prescribed antimicrobials among MDRGN raises concerns about therapeutic options available to treat MDRGN infections among LTCF residents.
Figures
Similar articles
-
High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.PLoS One. 2019 Sep 12;14(9):e0222200. doi: 10.1371/journal.pone.0222200. eCollection 2019. PLoS One. 2019. PMID: 31513682 Free PMC article.
-
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.Antimicrob Agents Chemother. 2008 Apr;52(4):1430-7. doi: 10.1128/AAC.01538-07. Epub 2008 Feb 19. Antimicrob Agents Chemother. 2008. PMID: 18285482 Free PMC article.
-
Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents.Infect Control Hosp Epidemiol. 2003 Apr;24(4):246-50. doi: 10.1086/502201. Infect Control Hosp Epidemiol. 2003. PMID: 12725352
-
[Development of antimicrobial resistance in Germany : What is the current situation?].Med Klin Intensivmed Notfmed. 2017 Apr;112(3):186-191. doi: 10.1007/s00063-017-0272-2. Epub 2017 Apr 4. Med Klin Intensivmed Notfmed. 2017. PMID: 28378152 Review. German.
-
Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug?J Infect. 2013 May;66(5):401-14. doi: 10.1016/j.jinf.2012.10.028. Epub 2012 Nov 6. J Infect. 2013. PMID: 23142195 Review.
Cited by
-
Effectiveness of Antimicrobial Stewardship Program in Long-Term Care: A Five-Year Prospective Single-Center Study.Interdiscip Perspect Infect Dis. 2022 Apr 12;2022:8140429. doi: 10.1155/2022/8140429. eCollection 2022. Interdiscip Perspect Infect Dis. 2022. PMID: 35464254 Free PMC article.
-
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.Front Cell Infect Microbiol. 2022 Mar 15;12:823684. doi: 10.3389/fcimb.2022.823684. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35372099 Free PMC article. Review.
-
Evaluating the Prevalence and the Risk Factors of Gram-Negative Multi-Drug Resistant Bacteria in Eastern Saudi Arabia.Infect Drug Resist. 2022 Feb 17;15:475-490. doi: 10.2147/IDR.S350048. eCollection 2022. Infect Drug Resist. 2022. PMID: 35210791 Free PMC article.
-
Web-Based Interactive Tool to Identify Facilities at Risk of Receiving Patients with Multidrug-Resistant Organisms.Emerg Infect Dis. 2020 Sep;26(9):2046-2053. doi: 10.3201/eid2609.191691. Emerg Infect Dis. 2020. PMID: 32818409 Free PMC article.
-
Colonisation with pathogenic drug-resistant bacteria and Clostridioides difficile among residents of residential care facilities in Cape Town, South Africa: a cross-sectional prevalence study.Antimicrob Resist Infect Control. 2019 Nov 19;8:180. doi: 10.1186/s13756-019-0643-y. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31827776 Free PMC article.
References
-
- Spellberg B, Guidos R, Gilbert D, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Disease Society of America. Clin Infect Dis. 2008;46:155–164. - PubMed
-
- Muder RR, Breene C, Drenning SD, et al. Multiply antibiotic-resistant gram-negative bacilli in a long-term-care facility: a case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol. 1997;18:809–813. - PubMed
-
- Weiner J, Quinn JP, Bradford PA, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999;281:517–523. - PubMed
-
- Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother. 2004;48:2431–2436. - PMC - PubMed
-
- Pop-Vicas AE, D’Agata EM. The rising influx of multidrug-resistant gram negative bacilli into a tertiary care hospital. Clin Infect Dis. 2005;40:1792–1798. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
